Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4177641000168113 | Ondansetron (AFT) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4177651000168110 | Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | Is a | Ondansetron (AFT) | true | Inferred relationship | Some | ||
| Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | Is a | ondansetron 4 mg/2 mL injection, ampoule | true | Inferred relationship | Some | ||
| Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | has unit of use | ampoule | true | Inferred relationship | Some | 58524051 | |
| Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | has Australian BoSS | ondansetron | true | Inferred relationship | Some | 58524050 | |
| Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | has intended active ingredient | ondansetron | true | Inferred relationship | Some | 58524050 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | has TPUU | True | Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | Inferred relationship | Some | 1 |
| Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | has TPUU | True | Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | Inferred relationship | Some | 1 |
| Ondansetron (AFT) 4 mg/2 mL injection, 10 x 2 mL ampoules | has TPUU | True | Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | Inferred relationship | Some | 1 |
| Ondansetron (AFT) 4 mg/2 mL injection, 10 x 2 mL ampoules | has TPUU | True | Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | Inferred relationship | Some | 1 |
| Ondansetron (AFT) 4 mg/2 mL injection, 5 x 2 mL ampoules | has TPUU | True | Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | Inferred relationship | Some | 1 |
| Ondansetron (AFT) 4 mg/2 mL injection, 5 x 2 mL ampoules | has TPUU | True | Ondansetron (AFT) 4 mg/2 mL injection, 2 mL ampoule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR